We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006-2017.
- Authors
Neha, Reddy; Subeesh, Viswam; Beulah, Elsa; Gouri, Nair; Maheswari, Eswaran
- Abstract
The United States Food and Drug Administration (FDA) has licensed three HPV (Human papilloma virus) vaccines. The centers for disease control and prevention (CDC) and advisory committee on immunization practices (ACIP) recommends routine HPV vaccination at age 11 or 12 years. This study aimed to summarize and characterize adverse events following HPV vaccination reported to VAERS database from July 2006 to May 2017.
- Publication
Perspectives in clinical research, 2020, Vol 11, Issue 1, p24
- ISSN
2229-3485
- Publication type
Journal Article
- DOI
10.4103/picr.PICR_140_18